CONNAUGHTON BERNADETTE sold 4.4% of their position (2K shares) of HALOZYME THERAPEUTICS, INC. on the open market
Open‑market sale worth $137.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/12/2025ACC: 0001159036-25-000052
Director
Since Sep 2018
-2K
Net shares
Net seller
$137.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2K
Price / share
$68.48
Trade value
$136.96K
% of position
4.4%
11/10/2025
44.95K→42.95K
Total
Net shares
−2K
Net value
-$136.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/10/2025 | S · Sale | −2K | $68.48 | $136.96K | 4.4% | 44.95K | 42.95K |
| Total | −2K | -$136.96K | ||||||
Derivative Transactions0
No derivative transactions reported